Brainomix Launches Next-Generation AI-Driven Stroke Imaging Platform with Industry-First Net Water Uptake Technology
Published: 04 Feb 2026
Author: Precedence Research
This is the first step of Brainomix, a medical imaging innovator based in the U.S. that operates globally. The company launched its Brainomix 360 Stroke Next Generation platform at the International Stroke Conference (ISC) 2026. The release of the stroke diagnostics is a significant leap in the field of stroke diagnostics. The new platform enhances quicker and more assured clinical decision-making in a broad range of hospital environments throughout the globe by enhancing the diagnostic capability of regular imaging.
The successor product is based on the strong history of leadership in CT-based stroke imaging offered by Brainomix. It provides deeper insights without the need to use specialized or expensive imaging modalities. The combination of the technology release and the research demonstration highlight the ambitious struggle of the company to democratize access to the level of expertise in the assessment of strokes. This makes the results of the patients, irrespective of the geographical location and hospital capabilities, accessible.
Brainomix is ranked among the world's technology giants, including Apple, Sony, and Samsung. The platform includes advanced DICOM imaging, improved navigation, and AI-based and patient-centered insights that enable clinicians to quickly make interpretations of the images when time is of the essence. Brainomix 360 Stroke Next Generation is a solution to a dire gap in the workforce, with the growing global healthcare systems struggling to cope with the increasing cases of stroke and access to expertise in the field. Furthermore, the platform enables the smaller hospitals to match the big stroke centers by turning regular CT scans into powerful decision-support tools, thus facilitating the growing market presence of Brainomix in the coming years.
Executive Statement
Commenting on the launch, Dr. George Harston, Chief Medical and Innovation Officer at Brainomix and Consultant Stroke Physician at Oxford University Hospitals, said, “We are delighted to introduce this latest innovation in stroke AI imaging, building on our expertise in universally available CT imaging. The automated net water uptake output complements Brainomix’s unique ischemic core volume and e-ASPECTS features, providing clinicians with deeper insights into stroke injury from a routine non-contrast CT scan. As emerging evidence highlights NWU as a vital imaging biomarker, we believe this advancement can improve confidence and decision-making, even in the most severe stroke cases.”